MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-18-0061040
Novus Life Sciences Private Limited - pharma in Mumbi, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹109.09 Cr
▲ 96% YoY
Net profit · FY 2025
₹17.97 Cr
Net margin 16.5%
EBITDA · FY 2025
₹24.22 Cr
EBITDA margin 22.2%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.5 Cr
Issued & subscribed
Open charges
₹7.26 Cr
Secured borrowings
Company age
19 yrs
Est. 2007
Employees · EPFO
11
Provident fund records
About Novus Life Sciences Private Limited
Data last updated:
Novus Life Sciences Private Limited is a private limited company based in Mumbi, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 October 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24232MH2007PTC174821. Its GSTIN is 27AACCN6259P1ZR (Maharashtra). The company holds 5 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.5 Cr. It is led by directors including Manju Pramod Saraf and Pranav Pramod Saraf.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 506B Kenmore 2nd Cross Lane Lokhandwala Complex Andheri West, Mumbi, Maharashtra, India – 400053.
As per the financials filed for FY 2025, the company reported a revenue of ₹109.09 Cr, a growth of 96% compared to the previous year. For the same year it recorded a net profit of ₹17.97 Cr (net margin 16.5%) and EBITDA of ₹24.22 Cr (EBITDA margin 22.2%). Revenue has grown at a compounded annual rate (CAGR) of 37% over three years and 40% over five years.
The company has about 11 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Carbamide Forte. As per MCA filings, the company has open charges of ₹7.26 Cr on record. Court records list 1 case involving the company, including 1 filed against it. The company has 1 deal on record (1 rights issue); the latest was in March 2021. Its 3 peer companies in the Pharma industry (Formulations), with the same principal business activity (wholesale trading) are compared by revenue, 1 larger and 2 smaller; the largest is Auracare Pharma Private Limited with revenue of ₹111 Cr.
Novus Life Sciences Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-18-0061040). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website novuslifesciences.com.
Company details
CIN U24232MH2007PTC174821
Registration Number 174821
Incorporation Date 09 October 2007
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-18-0061040
Recognitions & Rankings of Novus Life Sciences
Contact details
Novus Life Sciences Private Limited's registered office is in Mumbi, Maharashtra. Its website is novuslifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address506B Kenmore 2nd Cross Lane Lokhandwala Complex Andheri West, Mumbi, Maharashtra, India – 400053
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Novus Life Sciences Private Limited, buy the company report.
Comprehensive company report
Novus Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Novus Life Sciences operates one associated brand: Carbamide Forte. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Online platform selling vitamins, supplements, and wellness products to consumers. | mycf.in |
Business activity
The main business activity of Novus Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Novus Life Sciences Private Limited, buy the company report.
Financials of Novus Life Sciences Private Limited
FY 2025 filings availableNovus Life Sciences Private Limited reported revenue of ₹109.09 Cr (up 96% YoY) for FY 2025.
Revenue · FY 2025
₹109.09 Cr ▲ 96%
Net profit · FY 2025
₹17.97 Cr margin 16.5%
EBITDA · FY 2025
₹24.22 Cr margin 22.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 96%
3 years · compounded
▲ 37%
5 years · compounded
▲ 40%
EBITDA CAGR growth
1 year
▲ 198%
3 years · compounded
▲ 57%
5 years · compounded
▲ 65%
Revenue has grown at a compounded annual rate (CAGR) of 40% over five years, including 96% growth in the latest year. EBITDA rose 198% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹109.09 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹24.22 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17.97 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.2% | ||||
| Net Profit Margin | 16.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Novus Life Sciences Private Limited, buy the company report.
Board of directors of Novus Life Sciences Private Limited
Novus Life Sciences has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manju Pramod Saraf | Director | 20 Oct 2023 | 3 Years 0 Months | Current |
| Pranav Pramod Saraf Also directs: Mahogany Holidays Private Limited | Director | 08 Nov 2013 | 12 Years 11 Months | Current |
| Ritika Pramod Saraf Also directs: Mahogany Holidays Private Limited | Director | 09 Dec 2017 | 8 Years 10 Months | Current |
| Pramod Sitaram Saraf | Director | 20 Oct 2023 | 3 Years 0 Months | Current |
Peer comparison
Novus Life Sciences Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Auracare Pharma Private Limited | ₹111 Cr (FY 2025) | 11.0% | Ahmedabad, Gujarat, India | |||
| Novus Life Sciences Private Limitedthis company | ₹109.09 Cr (FY 2025) | ₹17.97 Cr | 16.5% | 96.0% | Mumbi, Maharashtra, India | |
| Meyonex Pharmaceuticals Limited | ₹108.15 Cr (FY 2025) | -19.0% | Palghar, Maharashtra, India | |||
| Unimed Technologies Limited. | ₹107.74 Cr (FY 2025) | 11.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Novus Life Sciences Private Limited, buy the company report.
Auditor
Novus Life Sciences Private Limited is audited by CHINMAY SHAH AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CHINMAY SHAH AND ASSOCIATES | FY 2023 | 140279W |
Shareholding
The shareholding of Novus Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Novus Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹7.26 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Nov 2024 | 101029051 | Hdfc Bank Limited | ₹2.5 Cr | Open | |
| 01 Mar 2024 | 100888027 | Hdfc Bank Limited | ₹2.8 Cr | Open | |
| 10 Aug 2023 | 100790372 | Others | ₹66 Lakh | Open | |
| 11 Sep 2013 | 10470569 | Indian Bank | ₹1.3 Cr | Open |
To see the full charge records of Novus Life Sciences Private Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Novus Life Sciences Private Limited has 1 deal on record (1 rights issue); the latest was in March 2021.
Total deals
1
Rights issue
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Rights issue | ₹1 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Novus Life Sciences Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Pune, Maharashtra | Civil suit | Filed against the company by M/S Cian Health Care Pvt. Ltd. Through Shashikant Vasant Vahalkar | Disposed |
To see the full case history of Novus Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Novus Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Novus Life Sciences has 5 GST registrations: 4 active and 1 cancelled or inactive.
Total GSTINs
5
Active
4
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCN6259P1ZR | Maharashtra | Active | 01 Jul 2017 |
| 33AACCN6259P1ZY | Tamil Nadu | Active | 09 Jun 2018 |
| 19AACCN6259P1ZO | West Bengal | Active | 05 Jul 2018 |
| 29AACCN6259P1ZN | Karnataka | Active | 31 Oct 2018 |
To see the full GST registrations and return filing status of Novus Life Sciences Private Limited, buy the company report.
Recent activity
Novus Life Sciences Private Limited has 7 board changes on record since 2013: 4 appointments and 3 cessations. The latest: Pranav Pramod Saraf ceased to be Additional Director on 29 Sep 2024.
Filing
Novus Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2.50 Cr with Charge ID 101029051 was registered on 28 Nov 2024.
AGM
Novus Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Pranav Pramod Saraf ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 2.80 Cr with Charge ID 100888027 was registered on 01 Mar 2024.
Appointed
Manju Pramod Saraf was appointed as Director.
Appointed
Pramod Sitaram Saraf was appointed as Director.
Charges
A charge with Others amounted to Rs. 0.66 Cr with Charge ID 100790372 was registered on 10 Aug 2023.
Charges
A charge with Indian Bank of Rs. 1.30 Cr registered on 11 Sep 2013 with Charge ID 10470569 was modified on 26 May 2022.
Ceased
Manju Pramod Saraf ceased to be Director.
Ceased
Pramod Sitaram Saraf ceased to be Director.
Appointed
Ritika Pramod Saraf was appointed as Director.
3 earlier events are in the company report.
Frequently asked questions
Novus Life Sciences is an active private limited company based in Mumbi, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 October 2007 (19+ years old) and is registered under CIN U24232MH2007PTC174821.
Novus Life Sciences has 4 current directors:
- Manju Pramod Saraf - Director
- Pranav Pramod Saraf - Director
- Ritika Pramod Saraf - Director
- Pramod Sitaram Saraf - Director
The latest financial statements of Novus Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Novus Life Sciences is 27AACCN6259P1ZR, registered in Maharashtra. The company has 5 GST registrations in all, of which 4 are active and 1 is cancelled or inactive. Other active GSTINs include 33AACCN6259P1ZY (Tamil Nadu), 19AACCN6259P1ZO (West Bengal), 29AACCN6259P1ZN (Karnataka).
The CIN (Corporate Identification Number) of Novus Life Sciences is U24232MH2007PTC174821. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novus Life Sciences has 1 court case on record: 1 filed against it.
Novus Life Sciences was incorporated on 09 October 2007, making it 19+ years old. It is registered with the Registrar of Companies, Mumbai.
Novus Life Sciences has 1 deal on record (1 rights issue); the latest was in March 2021.
The peers of Novus Life Sciences by revenue are Auracare Pharma Private Limited, Meyonex Pharmaceuticals Limited, Unimed Technologies Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Pranav Pramod Saraf ceased to be Additional Director on 29 Sep 2024. Manju Pramod Saraf was appointed as Director on 20 Oct 2023. Pramod Sitaram Saraf was appointed as Director on 20 Oct 2023. Novus Life Sciences has 7 board changes on record in total.
Yes, Novus Life Sciences is registered as an MSME under Udyam registration (number: UDYAM-MH-18-0061040).